Whole genome sequence data of Stenotrophomonas maltophilia SCAID WND1-2022 (370)

Ilya Korotetskiy1, Ardak Jumagaziyeva1, Bahkytzhan Kerimzhanova1

  • 1JSC Scientific Center for Anti-Infectious Drugs, Almaty, Kazakhstan.

Data in Brief
|November 25, 2022
PubMed

Insights

The whole genome of the hospital pathogen Stenotrophomonas maltophilia SCAID WND1-2022 was sequenced, revealing antibiotic resistance and virulence genes. A unique plasmid may contribute to pathogenicity but not drug resistance.

Area of Science:

  • Microbiology
  • Genomics
  • Bioinformatics

Background:

  • Stenotrophomonas maltophilia is an opportunistic pathogen frequently associated with hospital-acquired infections.
  • Understanding the genomic basis of its virulence and antibiotic resistance is crucial for effective treatment and control.

Purpose of the Study:

  • To report the complete genome sequence of Stenotrophomonas maltophilia SCAID WND1-2022, a hospital infection agent.
  • To identify genes associated with antibiotic resistance and virulence within this strain.
  • To characterize the genetic elements, including plasmids, that contribute to the pathogen's characteristics.

Main Methods:

  • Whole genome sequencing using PacBio technology.
  • Bioinformatic analysis for genome assembly and annotation.
  • Comparative genomics to determine taxonomic provenance and identify specific genes.

Main Results:

  • The genome consists of a 4.88 Mb chromosome and a 38.6 Kb plasmid.
  • Identified numerous antibiotic resistance genes (efflux pumps, beta-lactamases) and virulence factors (biofilm formation) on the chromosome.
  • The plasmid is novel and appears to contribute to virulence but not antibiotic resistance.

Conclusions:

  • The genome sequence provides a valuable resource for studying Stenotrophomonas maltophilia.
  • The identified resistance and virulence genes highlight potential therapeutic targets.
  • The unique plasmid may represent a novel factor in pathogen evolution and host interaction.